StockData
Decoy Therapeutics Inc. logo

Decoy Therapeutics Inc. (DCOY) stock

DCOYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.95+0.05 (+5.37%)

Close on Nov 17, 2026Market cap $622.03KP/E –Yield –

Decoy Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Decoy Therapeutics's price to book ratio was 0.1× on Nov 11, 2026, against 2.5× a year earlier. Over the last 5 years it ranged from 0.1× to 361.8×, with a median of 4.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.1×−1.6
2025Dec 31, 20251.7×−9.1
2024Dec 31, 202410.9×+5.8
2023Dec 29, 20235.0×+2.6
2022Dec 30, 20222.5×−3.8
2021Dec 31, 20216.3×−4.2
2020Dec 31, 202010.5×−7.0
2019Dec 31, 201917.5×−301.8
2017Oct 31, 2017319.3×−77.0
2016Dec 30, 2016396.3×−97.2
2015Oct 30, 2015493.4×–

More Decoy Therapeutics figures

See a number that looks wrong?